A detailed history of Oakworth Capital, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Oakworth Capital, Inc. holds 50 shares of EMBC stock, worth $1,014. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$1,014
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$12.35 - $19.33 $2,692 - $4,213
-218 Reduced 81.34%
50 $0
Q3 2023

Oct 31, 2023

SELL
$15.0 - $22.17 $30 - $44
-2 Reduced 0.74%
268 $4,000
Q2 2022

Aug 05, 2022

BUY
$24.78 - $33.36 $6,690 - $9,007
270 New
270 $7,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Oakworth Capital, Inc. Portfolio

Follow Oakworth Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.